Jeff Baxter - 17 Jun 2021 Form 4 Insider Report for ChromaDex Corp. (NAGE)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
22 Jun 2021, 17:28:05 UTC
Next SEC filing
31 Jan 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jeong James Lee, Attorney-in-Fact

Key filing fact

Jeff Baxter filed Form 4 for ChromaDex Corp. (NAGE) on 22 Jun 2021.

Key facts

  • This page summarizes Jeff Baxter's Form 4 filing for ChromaDex Corp. (NAGE).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 22 Jun 2021, 17:28.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CDXC transaction Derivative

Stock Options (right to buy)

Award

Transaction value
$0
Shares
+20,000
Change %
Price
$0.000000
Shares after
20,000
Date
17 Jun 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
20,000
Exercise price
$9.99
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Options vest 100% on June 17, 2022

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .